SDHB p.Arg46Leu
Variant summary
The NM_003000.3(SDHB):c.137G>T (p.Arg46Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00000137 (AC=2) in the gnomAD database across 1,461,790 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000003. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000554015: Experimental studies have shown that this missense change affects SDHB function (PMID:23175444)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R46G: Pathogenic (ClinVar VariationId 12785, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R46?: Uncertain_significance (ClinVar VariationId 591278, 0 stars); p.R46P: Uncertain_significance (ClinVar VariationId 3756934, 1 star); p.R46= (synonymous): Likely_benign (ClinVar VariationId 1100244, 1 star); p.R46= (synonymous): Benign/Likely_benign (ClinVar VariationId 646758, 2 stars); p.R46= (synonymous): Likely_benign (ClinVar VariationId 937404, 1 star)
Frequency
Consequence
NM_003000.3 missense
Scores
Clinical Significance
Conservation
Publications
- Carney-Stratakis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- pheochromocytoma/paraganglioma syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- mitochondrial complex 2 deficiency, nuclear type 4Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial complex II deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 16 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000554015: Experimental studies have shown that this missense change affects SDHB function (PMID: 23175444).; SCV000664561: This alteration has been reported in a paraganglioma-pheochromocytoma cohort, and authors characterized this alteration as having severely impaired function based on reduced oxidative growth, SDH activity and respiration, as well as increased mtDNA mutability following oxidative stress (Panizza E et al. Hum. Mol. Genet., 2013 Feb;22:804-15).; SCV005202014: Functional assays in yeast demonstrated that this variant affects SDH enzyme activity (PMID: 23175444) | ||
| PM1Mutational hot spot or critical domain | UniProt domain with ≥4 pathogenic missense and OR ≥ 5 vs. background — hotspot (PM1); In-domain: 121 pathogenic, 13 benign rare missense variants (OR vs. background: 45.0).; ±8 AA neighbourhood: 5 pathogenic, 2 benign (OR vs. background: 11.0). | ||
| PM2Absent/extremely low in population databases | Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.0000003 — very rare for AD+AR gene (threshold 0.0001) — PM2 moderate. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R46G: Pathogenic (ClinVar VariationId 12785, 2 stars); Other variants at the same amino acid residue (not pathogenic): p.R46?: Uncertain_significance (ClinVar VariationId 591278, 0 stars); p.R46P: Uncertain_significance (ClinVar VariationId 3756934, 1 star); p.R46= (synonymous): Likely_benign (ClinVar VariationId 1100244, 1 star); p.R46= (synonymous): Benign/Likely_benign (ClinVar VariationId 646758, 2 stars); p.R46= (synonymous): Likely_benign (ClinVar VariationId 937404, 1 star) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_003000.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SDHB | MANE Select | c.137G>T p.Arg46Leu | missense | Exon 2 of 8 | Prot: NP_002991.2 UniProt: | |
SDHB | c.137G>T p.Arg46Leu | missense | Exon 2 of 8 | Prot: NP_001394290.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SDHB | TSL:1MANE Select | c.137G>T p.Arg46Leu | missense | Exon 2 of 8 | Prot: ENSP00000364649.3 UniProt: | |
SDHB | c.182G>T p.Arg61Leu | missense | Exon 3 of 9 | Prot: ENSP00000519325.1 UniProt: | ||
SDHB | c.137G>T p.Arg46Leu | missense | Exon 2 of 8 | Prot: ENSP00000595680.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | AF: 0.00000137 | AC:2 | Hom:0 | AN:1461790 | Cov:32 |
GnomAD4 genome | Cov:32 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 31 | |
AlphaMissense | Pathogenic | 0.99 | |
BayesDel_addAF | Pathogenic | 0.57 | D |
BayesDel_noAF | Pathogenic | 0.58 | |
CADD | Pathogenic | 33 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.94 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 1.0 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
FuncVEP CTI | Pathogenic | 0.98 | |
GPN-Star LLR | N/A | -8.8 | |
GPN-Star score | N/A | 8.8 | |
LIST_S2 | Pathogenic | 1.0 | D |
M_CAP | Pathogenic | 0.70 | D |
MetaRNN | Pathogenic | 0.98 | D |
MetaSVM | Pathogenic | 0.95 | D |
Mutation Taster | N/A | 10/90 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 4.6 | H |
PhyloP100 | Uncertain | 7.1 | |
popEVE | Benign | -3.8 | |
PrimateAI | Uncertain | 0.63 | T |
PromoterAI | N/A | -0.051 | Neutral |
PROVEAN | Pathogenic | -5.5 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Pathogenic | 0.93 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.96 | |
VESM-3B | Benign | -13 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.